Executive that leads global strategy, business development, markets, commercial, product launch, licensing, deal negotiation, P&L, and matrix cross-functional teams to achieve goals. Innovative thinker with deep gene therapy, rare disease, and biotechnology industry acumen. Demonstrates success in developing and executing plans in complex global, fast-paced, regulated environments. Creates and implements impactful strategies by analyzing details to understand competitors, trends, regulations, and partner relationships. Converts chaos to performance and complicated topics into simple concepts. Organized, creative problem-solver who excels at guiding teams through challenging emerging markets. Expertise managing $300M budgets and improving global, regional, and country-level growth. Shares contrarian perspectives when advising C-level executives and boards of directors.Accomplishments:• 24 years of leadership at CANbridge, Bioverativ (Sanofi), Genzyme, Eli Lilly, • Oversee global gene therapy and rare disease early development to commercial stage go-to-market planning, marketing, sales, contracts, negotiations, P&L, finance, regulatory, access, research partners, forecasts, metrics, reports, and 42 staff.• Bought license rights from 7 companies to develop and commercialize rare disease, gene therapy, and oncology products.• Launched new products, managed early and mature stage businesses, orphan drugs.• Led turnaround in the Mexican Genzyme affiliate that was experiencing declining revenue.• MBA, University of North CarolinaExpertise:• Strategic Planning • Product Launch • Commercial & Business Development • Global Market Access • Alliance Management • Gene Therapy, Rare, Orphan Disease • Oncology • Product Development • Government Regulations • IPO • Deal Structuring • Due Diligence • Complement-Mediated Disorders • Lysosomal Storage Disorders • Hemophilia • Metabolic Disorders • Neuromuscular Diseases • Cholestatic Liver Diseases • Pricing • P&L, Budget • Market Research • Performance Turnaround • Process Improvement • Diversity, Inclusion • Operations • Clinical, Medical Affairs • Organization Design • Problem Solving • Alliance Management • Biotechnology • Spanish, Portuguese Languages.